Celastrol inhibits cancer metastasis by suppressing M2-like polarization of macrophages
Related Experiment Video
Updated: Feb 12, 2026

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
Yuening Yang1, Shuyuan Cheng2, Guikai Liang2
1Hangzhou Xuejun High School, PR China.
Abstract:
In recent years, a large amount of clinical and experimental data has shown that M2-like polarized tumor-associated macrophages (TAMs) play an important role in cancer metastasis. Therefore, TAMs, especially M2-like TAMs is a promising target for anti-tumor metastasis therapy. Here, we found that celastrol dose-dependently suppressed IL-13 induced CD206 expression both in RAW264.7 and in primary macrophages. Consistently, celastrol also inhibited the expression of M2-like specific genes, including MRC1, Arg1, Fizz1, Mgl2 and CD11c. Further, by the employment of 4T1 breast cancer model, we found that celastrol significantly prevented cancer metastasis in vivo. Mechanistically, celastrol completely ameliorated STAT6 phosphorylation, which is the key signal molecule responsible for M2 polarization. Our research puts forward a new application of celastrol in anti-cancer metastasis, by intervening M2-like polarization through inhibiting STAT6.
Insights
Celastrol inhibits M2-like tumor-associated macrophages (TAMs) polarization by blocking STAT6 signaling. This finding presents celastrol as a potential therapeutic agent to prevent cancer metastasis.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- M2-like tumor-associated macrophages (TAMs) promote cancer metastasis.
- Targeting M2-like TAMs is a promising strategy for anti-cancer metastasis therapy.
Purpose of the Study:
- To investigate the effect of celastrol on M2-like TAM polarization.
- To explore the potential of celastrol as an anti-metastasis agent.
Main Methods:
- Celastrol's effect on IL-13 induced CD206 expression in macrophages was assessed.
- M2-like specific gene expression (MRC1, Arg1, Fizz1, Mgl2, CD11c) was analyzed.
- The 4T1 breast cancer metastasis model was used to evaluate celastrol in vivo.
- STAT6 phosphorylation was measured to understand the mechanism of action.
Main Results:
- Celastrol suppressed IL-13 induced CD206 expression and M2-like specific genes in macrophages.
- Celastrol significantly inhibited cancer metastasis in the 4T1 breast cancer model.
- Celastrol ameliorated STAT6 phosphorylation, a key mediator of M2 polarization.
Conclusions:
- Celastrol effectively inhibits M2-like TAM polarization by targeting STAT6 signaling.
- Celastrol demonstrates potential as a therapeutic agent for preventing cancer metastasis.
Related Concept Videos
Group Polarization
Feedback Inhibition
Molecular Shape and Polarity
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Polar Coordinates
Enzyme Inhibition

